HealthTech.euabout 1 hour ago
MucoLife Secures €91K for COPD Drug
1 min read
MucoLife Therapeutics receives €91,000 from Vinnova to scale manufacturing of MLT-001, a peptide treating COPD. CEO Thaher Pelaseyed states the funds will build a purification process for the drug to move closer to clinical trials.
Level
Hype check
Tap to vote and see what everyone thinks.
